Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy.
The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention.
Effect of Bronchoconstriction on Airway Remodeling in Asthma.
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers.
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer.
Trends in Hospital Volume and Operative Mortality for High-Risk Surgery.
Abstracts and Insights From AAN 2011: Update on Developments in MS Treatment.
regards, taniafdi ^_^
No comments:
Post a Comment